Literature DB >> 16334758

Metastatic potential in T1 and T2 colorectal cancer.

Wen-Liang Fang1, Shih-Ching Chang, Jen-Kou Lin, Haunn-Sheng Wang, Shung-Haur Yang, Jen-Kae Jiang, Wei-Chone Chen, Tzu-Chen Lin.   

Abstract

BACKGROUND/AIMS: Survival of patients with colorectal cancer confined to the muscularis propria (stage I) is excellent after curative resection. However, some patients are likely to develop lymph node and distant metastasis that can ultimately cause death. The purpose of this study was to identify the possible predictors of lymph node and distant metastasis in T1 and T2 colorectal cancers.
METHODOLOGY: In total 208 patients with T1 and T2 colorectal cancers who underwent surgical resection in Taipei Veterans General Hospital from July 1996 to December 2001 were enrolled. The clinicopathological variables including age, gender, tumor location (rectum/colon), preoperative carcinoembryonic antibody level, depth of tumor invasion, lymphovascular invasion, and unfavored histology corresponding to the metastasis assessed pathologically were analyzed. Categorical variables were analyzed using Chi-square with Yates' correction. The independent predictor of lymph node and distant metastasis was determined with multivariate binary logistic regression.
RESULTS: Of the 208 T1 and T2 colorectal cancer patients, 36 (17.3%) had lymph node metastasis and 5 (2.4%) had distant metastasis at surgery. The risk of lymph node metastasis was 14.3% (8/56) in T1 and 18.4% (28/52) in T2 colorectal cancer. The tumors with evidence of lymphovascular invasion had a significantly higher incidence of lymph node metastasis than those without lymphovascular invasion (43.6% vs. 9.4%; p<0.001). The independent risk factor for lymph node metastasis was lymphovascular invasion only (95% confidence interval, 3.37-19.97; p<0.001), whereas that for distant metastasis was preoperative carcinoembryonic antibody level >5ng/mL only (95% confidence interval, 0.03-0.21; p<0.001). The negative predictive value of possible adverse risk factors including preoperative carcinoembryonic antibody level >5ng/mL, lymphovascular invasion, and unfavored differentiation for metastasis was 93.5%.
CONCLUSIONS: Considering the negative predictive value of combined possible adverse risk factors, the risk of metastasis still was 6.5%. Therefore radical surgery was recommended for all T1 and T2 stage colorectal cancer patients except if the patient had a very high surgical risk.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16334758

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  28 in total

1.  Functional and clinical results of transanal endoscopic microsurgery combined with endoscopic posterior mesorectum resection for the treatment of patients with t1 rectal cancer.

Authors:  Piotr Walega; Jakub Kenig; Piotr Richter; Wojciech Nowak
Journal:  World J Surg       Date:  2010-07       Impact factor: 3.352

2.  Population-based screening improves histopathological prognostic factors in colorectal cancer.

Authors:  Mónica Mengual-Ballester; Enrique Pellicer-Franco; Graciela Valero-Navarro; Victoriano Soria-Aledo; José Andrés García-Marín; José Luis Aguayo-Albasini
Journal:  Int J Colorectal Dis       Date:  2017-11-14       Impact factor: 2.571

3.  Lymphovascular or perineural invasion may predict lymph node metastasis in patients with T1 and T2 colorectal cancer.

Authors:  Jung Wook Huh; Hyeong Rok Kim; Young Jin Kim
Journal:  J Gastrointest Surg       Date:  2010-04-30       Impact factor: 3.452

4.  Rectal cancer confined to the bowel wall: the role of 3 Tesla phased-array MR imaging in T categorization.

Authors:  Hale Çolakoğlu Er; Elif Peker; Ayşe Erden; İlhan Erden; Ethem Geçim; Berna Savaş
Journal:  Br J Radiol       Date:  2017-11-21       Impact factor: 3.039

Review 5.  Surgical Options in the Treatment of Lower Gastrointestinal Tract Cancers.

Authors:  Andrea S Porpiglia; Elin R Sigurdson
Journal:  Curr Treat Options Oncol       Date:  2015-09

6.  A multi-center study of using carbon nanoparticles to track lymph node metastasis in T1-2 colorectal cancer.

Authors:  Jun Yan; Fangqin Xue; Hongyuan Chen; Xiufeng Wu; Hui Zhang; Gang Chen; Jianping Lu; Lisheng Cai; Gao Xiang; Zhenwei Deng; Yu Zheng; Xiaoling Zheng; Guoxin Li
Journal:  Surg Endosc       Date:  2014-06-17       Impact factor: 4.584

7.  TisN0M1 Sigmoid Colon Cancer: A Case Report.

Authors:  Kyung Ha Lee; Jin Su Kim; Kwang Sik Cheon; In Sang Song; Dae Young Kang; Ji Yeon Kim
Journal:  Ann Coloproctol       Date:  2014-06-23

8.  Local Excision vs. Radical Resection in T1-2 Rectal Carcinoma: Results of a Study From the Surveillance, Epidemiology, and End Results (SEER) Registry Data.

Authors:  L J Hazard; D C Shrieve; B Sklow; L Pappas; K M Boucher
Journal:  Gastrointest Cancer Res       Date:  2009-05

Review 9.  Surgical treatment for rectal cancer: an international perspective on what the medical gastroenterologist needs to know.

Authors:  Rolv-Ole Lindsetmo; Yong-Geul Joh; Conor-P Delaney
Journal:  World J Gastroenterol       Date:  2008-06-07       Impact factor: 5.742

10.  The concurrence of histologically positive resection margins and sessile morphology is an important risk factor for lymph node metastasis after complete endoscopic removal of malignant colorectal polyps.

Authors:  Lars Boenicke; Martin Fein; Marco Sailer; Christoph Isbert; Christoph-Tomas Germer; Andreas Thalheimer
Journal:  Int J Colorectal Dis       Date:  2009-11-06       Impact factor: 2.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.